Qube Research & Technologies (QRT) Portfolio holdings
Qube Research & Technologies (QRT) is a British investment firm that trades with computer-driven models and began life inside Credit Suisse. It started in late 2016 as the Qube Fund, run by the bank's asset management unit for model-based strategies, and used computer models to trade stocks. Credit Suisse planned to spin the fund off because rules such as the Volcker Rule restricted banks from trading with their own money, and at the start of 2018 its management team bought the unit and renamed it Qube Research & Technologies. It runs a mix of strategies across many regions, asset classes and time horizons, with research teams of engineers, physicists, mathematicians, data scientists and fundamental analysts.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$1.31B |
| 2 |
NVIDIA
NVDA
|
+$1.03B |
| 3 |
Meta Platforms (Facebook)
META
|
+$840M |
| 4 |
Shopify
SHOP
|
+$815M |
| 5 |
Caterpillar
CAT
|
+$639M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1B |
| 2 |
Chevron
CVX
|
+$834M |
| 3 |
Sandisk
SNDK
|
+$632M |
| 4 |
Intercontinental Exchange
ICE
|
+$490M |
| 5 |
ExxonMobil
XOM
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.18% |
| 2 | Technology | 19.85% |
| 3 | Financials | 12.83% |
| 4 | Industrials | 10.55% |
| 5 | Healthcare | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
401
Applied Industrial Technologies
AIT
$10.9B
| $73.7M | 0.06% |
221,655
+33,797
| +18% | +$11.3M |
2025 Q2
5 quarters
|
|
402
PUT
UnitedHealth
UNH
$365B
| $73.6M | 0.06% |
200,400
-88,000
| -31% | -$35.4M |
2022 Q3
16 quarters
|
|
403
Carlisle Companies
CSL
$15.3B
| $73.2M | 0.06% |
+227,191
| New | +$78.9M |
2026 Q3
0 quarters
|
|
404
VanEck Semiconductor ETF
SMH
$63B
| $73M | 0.06% |
119,811
+103,193
| +621% | +$59.1M |
2026 Q2
1 quarter
|
|
405
Equinix
EQIX
$104B
| $72.9M | 0.06% |
72,027
-167,412
| -70% | -$174M |
2023 Q3
12 quarters
|
|
406
PUT
SPDR Gold Trust
GLD
$130B
| $72.7M | 0.06% |
191,000
+190,500
| +38,100% | +$74.5M |
2026 Q1
2 quarters
|
|
407
First Citizens BancShares
FCNCA
$25.7B
| $72.6M | 0.06% |
35,236
+9,752
| +38% | +$21M |
2026 Q2
1 quarter
|
|
408
NXP Semiconductors
NXPI
$66.8B
| $72.4M | 0.06% |
304,989
-343,090
| -53% | -$83.6M |
2025 Q4
3 quarters
|
|
409
UiPath
PATH
$6.92B
| $72.3M | 0.06% |
+5,633,298
| New | +$78.3M |
2026 Q3
0 quarters
|
|
410
Regency Centers
REG
$13.9B
| $72.3M | 0.06% |
1,005,967
-863,894
| -46% | -$66.8M |
2026 Q1
2 quarters
|
|
411
Bank of Montreal
BMO
$120B
| $71.8M | 0.06% |
429,507
+301,869
| +237% | +$53.3M |
2024 Q4
7 quarters
|
|
412
PUT
TotalEnergies
TTE
$199B
| $71.4M | 0.06% |
832,100
-863,600
| -51% | -$74.7M |
2025 Q4
3 quarters
|
|
413
Dow Inc
DOW
$23.9B
| $71.4M | 0.06% |
2,591,325
-4,287,706
| -62% | -$128M |
2026 Q2
1 quarter
|
|
414
Versant Media Group
VSNT
$4.91B
| $70.7M | 0.06% |
2,230,935
+116,096
| +5% | +$4.29M |
2026 Q1
2 quarters
|
|
415
Zoetis
ZTS
$34.1B
| $70.7M | 0.06% |
1,012,739
-1,266,594
| -56% | -$94.7M |
2026 Q2
1 quarter
|
|
416
Willis Towers Watson
WTW
$30.9B
| $70.4M | 0.06% |
+244,110
| New | +$77.1M |
2026 Q3
0 quarters
|
|
417
Frontline
FRO
$10.5B
| $70.3M | 0.06% |
1,427,386
+742,528
| +108% | +$31.6M |
2025 Q4
3 quarters
|
|
418
Owens Corning
OC
$8.94B
| $69.7M | 0.06% |
+597,012
| New | +$83.4M |
2026 Q3
0 quarters
|
|
419
AstraZeneca
AZN
$286B
| $69.6M | 0.06% |
431,223
+55,750
| +15% | +$9.29M |
2026 Q1
2 quarters
|
|
420
Sysco
SYY
$38B
| $69.5M | 0.06% |
+892,113
| New | +$73.3M |
2026 Q3
0 quarters
|
|
421
PUT
Boeing
BA
$136B
| $69.4M | 0.06% |
373,000
+80,000
| +27% | +$17.2M |
2023 Q1
14 quarters
|
|
422
IQVIA
IQV
$43.7B
| $69.2M | 0.06% |
257,314
-21,772
| -8% | -$5.26M |
2026 Q2
1 quarter
|
|
423
Oscar Health
OSCR
$9.6B
| $69.2M | 0.06% |
2,242,703
+1,158,764
| +107% | +$35.6M |
2026 Q1
2 quarters
|
|
424
Credicorp
BAP
$29.3B
| $69M | 0.06% |
181,604
+124,595
| +219% | +$47.9M |
2023 Q2
13 quarters
|
|
425
Travere Therapeutics
TVTX
$4.86B
| $69M | 0.06% |
1,171,448
-271,782
| -19% | -$16.6M |
2024 Q4
7 quarters
|
|
Similar funds
Qube Research & Technologies (QRT)'s Q3 2026 Portfolio in Review
As of Q3 2026, Qube Research & Technologies (QRT) held 4,268 positions worth $123B, up 14% from $108B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Qube Research & Technologies (QRT) deployed $13.6B of net new capital in Q3 2026, opening 862 new positions and adding to 1,394 existing holdings. Its largest new stake was Caterpillar: 753,166 shares worth $611M.
By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1B trimmed.
- Qube Research & Technologies (QRT)'s largest Q3 2026 buy was Caterpillar: 753,166 shares worth $611M.
- Qube Research & Technologies (QRT) added most to Warner Bros in Q3 2026, an estimated $1.31B increase.
- Qube Research & Technologies (QRT)'s biggest Q3 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1B.
- Qube Research & Technologies (QRT) fully exited Intercontinental Exchange in Q3 2026, selling an estimated $490M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $123B portfolio in Q3 2026.
- Qube Research & Technologies (QRT) opened 862 new positions and closed 641 in Q3 2026.
- Qube Research & Technologies (QRT)'s portfolio value rose 14% quarter-over-quarter to $123B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.